Procter & Gamble Health Limited (PGHL) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.278x

Based on the latest financial reports, Procter & Gamble Health Limited (PGHL) has a cash flow conversion efficiency ratio of 0.278x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs1.72 Billion ≈ $18.63 Million USD) by net assets (Rs6.20 Billion ≈ $67.02 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Procter & Gamble Health Limited defensive liquidity buffer to measure how many days the company can operate on defensive assets alone.

Procter & Gamble Health Limited - Cash Flow Conversion Efficiency Trend (2003–2024)

This chart illustrates how Procter & Gamble Health Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Procter & Gamble Health Limited Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Procter & Gamble Health Limited ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Xeris Pharmaceuticals Inc NASDAQ:XERS	0.759x
Sichuan Yimikang Environmental Tech Co Ltd SHE:300249	0.053x
Hagar hf IC:HAGA	0.078x
PROS Holdings Inc NYSE:PRO	-0.149x
Aktis Oncology, Inc. Common stock NASDAQ:AKTS	0.097x
Suburban Propane Partners LP NYSE:SPH	0.156x
VIEL & Cie société anonyme PA:VIL	0.111x
Paras Defence and Space Technologies Limited NSE:PARAS	-0.021x

Annual Cash Flow Conversion Efficiency for Procter & Gamble Health Limited (2003–2024)

The table below shows the annual cash flow conversion efficiency of Procter & Gamble Health Limited from 2003 to 2024. For the full company profile with market capitalisation and key ratios, see Procter & Gamble Health Limited market capitalisation.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	Rs5.37 Billion ≈ $58.07 Million	Rs1.76 Billion ≈ $19.02 Million	0.327x	-22.79%
2023-12-31	Rs5.38 Billion ≈ $58.21 Million	Rs2.28 Billion ≈ $24.69 Million	0.424x	+34.94%
2022-12-31	Rs7.51 Billion ≈ $81.21 Million	Rs2.36 Billion ≈ $25.52 Million	0.314x	+14.30%
2021-12-31	Rs6.16 Billion ≈ $66.67 Million	Rs1.70 Billion ≈ $18.33 Million	0.275x	-21.74%
2020-12-31	Rs7.04 Billion ≈ $76.10 Million	Rs2.47 Billion ≈ $26.74 Million	0.351x	+7.61%
2019-12-31	Rs9.06 Billion ≈ $98.02 Million	Rs2.96 Billion ≈ $32.00 Million	0.327x	+485.69%
2018-12-31	Rs15.40 Billion ≈ $166.56 Million	Rs-1.30 Billion ≈ $-14.10 Million	-0.085x	-215.68%
2017-12-31	Rs7.33 Billion ≈ $79.30 Million	Rs536.60 Million ≈ $5.80 Million	0.073x	-55.87%
2016-12-31	Rs6.45 Billion ≈ $69.80 Million	Rs1.07 Billion ≈ $11.58 Million	0.166x	+17.26%
2015-12-31	Rs5.92 Billion ≈ $63.97 Million	Rs836.60 Million ≈ $9.05 Million	0.141x	+1483.68%
2014-12-31	Rs5.54 Billion ≈ $59.95 Million	Rs49.50 Million ≈ $535.32K	0.009x	+937.95%
2013-12-31	Rs5.23 Billion ≈ $56.56 Million	Rs4.50 Million ≈ $48.67K	0.001x	-99.23%
2012-12-31	Rs4.84 Billion ≈ $52.31 Million	Rs542.60 Million ≈ $5.87 Million	0.112x	+280.13%
2011-12-31	Rs4.10 Billion ≈ $44.35 Million	Rs-255.40 Million ≈ $-2.76 Million	-0.062x	-132.70%
2010-12-31	Rs3.46 Billion ≈ $37.46 Million	Rs659.70 Million ≈ $7.13 Million	0.190x	+113.20%
2009-12-31	Rs4.67 Billion ≈ $50.54 Million	Rs417.40 Million ≈ $4.51 Million	0.089x	+936.50%
2008-12-31	Rs4.51 Billion ≈ $48.82 Million	Rs38.90 Million ≈ $420.69K	0.009x	-90.44%
2007-12-31	Rs4.23 Billion ≈ $45.74 Million	Rs381.10 Million ≈ $4.12 Million	0.090x	-56.34%
2006-12-31	Rs3.93 Billion ≈ $42.50 Million	Rs811.20 Million ≈ $8.77 Million	0.206x	-20.21%
2005-12-31	Rs2.98 Billion ≈ $32.24 Million	Rs771.20 Million ≈ $8.34 Million	0.259x	-18.21%
2004-12-31	Rs2.48 Billion ≈ $26.84 Million	Rs784.90 Million ≈ $8.49 Million	0.316x	-14.07%
2003-12-31	Rs1.96 Billion ≈ $21.22 Million	Rs722.30 Million ≈ $7.81 Million	0.368x	--

About Procter & Gamble Health Limited

NSE:PGHL India Drug Manufacturers - Specialty & Generic

Market Cap

$1.12 Billion

Rs103.74 Billion INR

Market Cap Rank

#8579 Global

#420 in India

Share Price

Rs6249.50

Change (1 day)

+0.37%

52-Week Range

Rs4778.60 - Rs6581.50

All Time High

Rs6870.36